Patent №
US 11,526,953
Granted
2022-12-13
Filed 2019
Owner
IQVIA INC.
Lab
—
AI components
6
ml · nlp · vision · planning · evo · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16451097
Aspects of the subject matter described in this specification are embodied in systems and methods that utilize machine-learning techniques to evaluate clinical trial data using one or more learning models trained to identify anomalies representing adverse events associated with a clinical trial investigation. In some implementations, investigation data collected at a clinical trial site is obtained. A set of models corresponding to the clinical trial site is selected. Each model included in the set of models is trained to identify, based on historical investigation data collected at the clinical trial site, a distinct set of one or more indicators that indicate a compliance risk associated with the investigation data. A score for the clinical trial site is determined based on the investigation data relative to the historical investigation data. The score represents a likelihood that the investigation data is associated with at least one indicator representing the compliance risk.
AI classification
Ownership
IQVIA INC.
assignment · 495920570
Assignors
BONAGERI, VIRUPAXKUMAR, PATIL, RAJNEESH, THANGAVELU, NITHYANANDAN, HUANG, JIAN, A, VIJAY PRATAP
On an employer assignment, the assignors are typically the inventors.